Study of Biweekly Capecitabine Dosing With Bevacizumab for the Treatment of Metastatic Breast Cancer Based Upon the Norton-Simon Mathematical Model
Clinical trial NCT00468585 · COMPLETED
Trial details
- NCT number
- NCT00468585
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-06-01
- Primary completion
- 2011-04-01
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.